← Leaderboards

Lance L Munn

Massachusetts General Hospital

Google Scholar ↗PubMed ↗ORCID ↗

$15,934,149

Attributed

$21,758,175

Total exposure

16

Grants

13

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY2005–25

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$21,758,175 · 16

By mechanism

R01$13,336,189 · 7

P01$3,776,489 · 4

U01$3,062,772 · 1

R21$831,372 · 2

R56$442,500 · 1

K02$308,853 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Seemantini K Nadkarni$9,725,963
Charles Corey Hardin$1,548,703

Others in their field

Top investigators on “Cells”

Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
Barton F Haynes · Duke University$457,457,619
David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
Dennis R. Burton · Scripps Research Institute$278,781,854
Mary M Horowitz · Medical College Of Wisconsin$237,383,608

Research focus

CellsTumorBlood VesselsTissuesMathematical ModelPathway InteractionsResponseIn VivoMouse ModelAffectIntravital MicroscopyCancer CellPharmaceutical PreparationsTumor GrowthMalignant NeoplasmsAntibodiesMechanicsPreventImplantKineticsBiologyMediatingPhysiologicalMeasurement

Grant awards (69)

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance$623,782

U01 · FY2025 · CA · contact PI

Systems Biology of Antigen and T-Cell Transport in Cancer Immunotherapy$488,228

R01 · FY2025 · CA

Vascularized tumor explants for drug testing$378,078

R01 · FY2025 · CA · contact PI

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance$592,593

U01 · FY2024 · CA · contact PI

Systems Biology of Antigen and T-Cell Transport in Cancer Immunotherapy$463,816

R01 · FY2024 · CA

Vascularized tumor explants for drug testing$359,175

R01 · FY2024 · CA · contact PI

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance$611,307

U01 · FY2023 · CA · contact PI

Systems Biology of Antigen and T-Cell Transport in Cancer Immunotherapy$504,978

R01 · FY2023 · CA

Vascularized tumor explants for drug testing$370,516

R01 · FY2023 · CA · contact PI

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance$611,308

U01 · FY2022 · CA · contact PI

Vascularized tumor explants for drug testing$370,516

R01 · FY2022 · CA · contact PI

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance$623,782

U01 · FY2021 · CA · contact PI

Multiplexed device for rapid coagulopathy testing$462,000

R21 · FY2021 · EB · contact PI

Targeting glycocalyx-mediated mechanisms of tumor metastasis$453,981

R01 · FY2021 · CA · contact PI

Vascularized tumor explants for drug testing$378,078

R01 · FY2021 · CA · contact PI

Targeting glycocalyx-mediated mechanisms of tumor metastasis$453,981

R01 · FY2020 · CA · contact PI

Systems biology of lymphatic transport$579,065

R01 · FY2019 · HL · contact PI

Targeting glycocalyx-mediated mechanisms of tumor metastasis$440,363

R01 · FY2019 · CA · contact PI

Systems biology of lymphatic transport$579,389

R01 · FY2018 · HL · contact PI

Targeting glycocalyx-mediated mechanisms of tumor metastasis$453,981

R01 · FY2018 · CA · contact PI

Systems biology of lymphatic transport$579,683

R01 · FY2017 · HL · contact PI

Targeting glycocalyx-mediated mechanisms of tumor metastasis$471,731

R01 · FY2017 · CA · contact PI

Systems biology of lymphatic transport$579,944

R01 · FY2016 · HL · contact PI

Bioengineering and Biostatistics$209,578

P01 · FY2016 · CA · contact PI

Systems biology of lymphatic transport$595,855

R01 · FY2015 · HL · contact PI

Encouraging anastomosis of engrafted vascular networks$340,371

R01 · FY2015 · HL · contact PI

Bioengineering and Biostatistics$230,339

P01 · FY2015 · CA · contact PI

Encouraging anastomosis of engrafted vascular networks$338,713

R01 · FY2014 · HL · contact PI

Bioengineering and Biostatistics$227,457

P01 · FY2014 · CA · contact PI

Encouraging anastomosis of engrafted vascular networks$329,080

R01 · FY2013 · HL · contact PI

Flow-based remodeling and function of tumor vasculature$301,394

R01 · FY2013 · CA · contact PI

Bioengineering and Biostatistics$235,518

P01 · FY2013 · CA · contact PI

Encouraging anastomosis of engrafted vascular networks$341,244

R01 · FY2012 · HL · contact PI

Flow-based remodeling and function of tumor vasculature$320,632

R01 · FY2012 · CA · contact PI

Bioengineering and Biostatistics$210,080

P01 · FY2012 · CA · contact PI

Flow-based remodeling and function of tumor vasculature$320,632

R01 · FY2011 · CA · contact PI

Transvascular Transport During Normalization: Potential Surrogate Markers$346,627

P01 · FY2010 · CA · contact PI

Flow-based remodeling and function of tumor vasculature$326,553

R01 · FY2010 · CA · contact PI

Bioengineering Core$228,071

P01 · FY2010 · CA · contact PI

Blood rheology: analytical approaches to sickle cell disease$442,500

R56 · FY2009 · HL · contact PI

Transvascular Transport During Normalization: Potential Surrogate Markers$337,776

P01 · FY2009 · CA · contact PI

Bioengineering Core$241,985

P01 · FY2009 · CA · contact PI

Transvascular Transport During Normalization: Potential Surrogate Markers$324,912

P01 · FY2008 · CA · contact PI

Bioengineering Core$268,758

P01 · FY2008 · CA · contact PI

Microfluidic Device for Isolating Rare Blood Cells$157,500

R21 · FY2008 · CA · contact PI

Transvascular Transport During Normalization: Potential Surrogate Markers$320,602

P01 · FY2007 · CA · contact PI

Blood rheology, cell adhesion and endothelial activation$290,381

R01 · FY2007 · HL · contact PI

Bioengineering Core$284,096

P01 · FY2007 · CA · contact PI

Microfluidic Device for Isolating Rare Blood Cells$211,872

R21 · FY2007 · CA · contact PI

Blood rheology, cell adhesion and endothelial activation$299,054

R01 · FY2006 · HL · contact PI

Transvascular Transport During Normalization: Potential Surrogate Markers$170,943

P01 · FY2006 · CA · contact PI

Bioengineering Core$139,747

P01 · FY2006 · CA · contact PI

Blood rheology, cell adhesion and endothelial activation$305,643

R01 · FY2005 · HL

Blood Rheology and Leukocyte Mechanics$102,951

K02 · FY2005 · HL

Blood rheology, cell adhesion and endothelial activation$329,703

R01 · FY2004 · HL

Blood Rheology and Leukocyte Mechanics$102,951

K02 · FY2004 · HL

CELL-SURFACE ADHESION--INFLUENCE OF BLOOD RHEOLOGY$247,194

R01 · FY2003 · HL

Blood Rheology and Leukocyte Mechanics$102,951

K02 · FY2003 · HL

CELL-SURFACE ADHESION--INFLUENCE OF BLOOD RHEOLOGY$237,091

R01 · FY2002 · HL

Core--Bioengineering$0

P01 · FY2002 · CA

Determinants of transvascular transport$0

P01 · FY2002 · CA

CELL-SURFACE ADHESION--INFLUENCE OF BLOOD RHEOLOGY$238,133

R01 · FY2001 · HL

Core--Bioengineering$0

P01 · FY2001 · CA

Determinants of transvascular transport$0

P01 · FY2001 · CA

CELL-SURFACE ADHESION--INFLUENCE OF BLOOD RHEOLOGY$269,013

R01 · FY2000 · HL

Determinants of transvascular transport$0

P01 · FY2000 · CA

Core--Bioengineering$0

P01 · FY2000 · CA

Core--Bioengineering$0

P01 · FY2000 · CA

Determinants of transvascular transport$0

P01 · FY2000 · CA